Cargando…

Pilocytic astrocytoma: pathology, molecular mechanisms and markers

Pilocytic astrocytomas (PAs) were recognized as a discrete clinical entity over 70 years ago. They are relatively benign (WHO grade I) and have, as a group, a 10-year survival of over 90 %. Many require merely surgical removal and only very infrequently do they progress to more malignant gliomas. Wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, V. Peter, Jones, David T. W., Giannini, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436848/
https://www.ncbi.nlm.nih.gov/pubmed/25792358
http://dx.doi.org/10.1007/s00401-015-1410-7